Focused Ultrasound Foundation

Bone Metastases Clinical Trials

The following is a list of clinical trials that are currently ongoing for the treatment of pain resulting from metastatic bone tumors and multiple myeloma using MR-guided focused ultrasound. While InSightec's ExAblate 2000 system has already received regulatory approval in Europe for the commercial treatment of bone mets pain, pre-market clinical trials of this device are still underway for regulatory approval in the United States. Pre-market clinical trials for the palliation of bone mets pain are also underway for both the InSightec Conformal Bone system (Exablate 2100) and the Philips system.

ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Metastatic Bone Tumors for the Palliation of Pain

Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System

Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases